Ted,
I am very much with you on being realistic on the commercial side. We can't really put a whole lot into words.....I want to see the progress. News releases and conferences are great, but true value is something you can put into your hand at the end of the day.
You can't deny that the ELISA test offers more advantages than the Histo, Cryo, and Abbott Analyzer Serum test.
I believe that the success with the ELISA test does exactly what Dr. Moro stated,
"It demonstrates our success in understanding the very unusual chemistry of RECAF well enough to suit the practical needs of a commercial test. The results are excellent and provide further evidence of the value of the RECAF blood test for cancer detection."
I think it is going to take verification to bring Abbott back. In the grand scheme of things they didn't really put a whole lot into the development and got results >90%. One has to step back and ask is this real? BOCX needs to continue to build the mountain of evidence it needs to support its foundational claim.
Histo/cryo tests verified by Abbott Serum test.
Abbott Serum test verified by ELISA test.
Future:
ELISA test present to and verified by peers.
RECAF verified. Patent protection.
Flood gates open.
---
Questions:
When do we get a third license?!?
Show me duh money!!
